Qube Research & Technologies (QRT)
ARAV

Qube Research & Technologies (QRT)’s Aravive, Inc. Common Stock ARAV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-541
Closed -$67 – 5014
2023
Q4 		$67 Sell
541
-465
-46% -$64 ﹤0.01% 4051
2023
Q3 		$133 Buy
+1,006
New +$632 ﹤0.01% 3750
2023
Q2 		– Sell
-53,919
Closed -$108K – 3174
2023
Q1 		$108K Buy
+53,919
New +$101K ﹤0.01% 2108

Other funds holding ARAV

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ARAV Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2024, closing a stake of 541 shares — an estimated $67 sold.

Qube Research & Technologies (QRT) first reported a position in ARAV in Q1 2023 and held it in 3 quarters. The position peaked at $108K in Q1 2023. 3 funds tracked by Wall St. Rank hold ARAV as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Aravive, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 541 Aravive, Inc. Common Stock shares in Q1 2024, an estimated $67.
  • Qube Research & Technologies (QRT) first reported a position in Aravive, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Aravive, Inc. Common Stock position peaked at $108K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.